PURPOSE: Despite implementation of newborn screening (NBS), outcomes in cobalamin C disease (cblC) remain poor. Therapy with hydroxycobalamin and betaine is widely used, but dietary recommendations vary among metabolic centers. We present a longitudinal analysis of the relationship between metabolic control, diet, and outcomes in a cohort of cblC patients. METHODS: We completed a retrospective analysis of 12 patients with cblC referred for abnormal NBS results and followed in our center between 1999 and 2015. RESULTS: Of the patients, 87.5% had intellectual disability and 75% had retinopathy; 16.7% had one episode of mild acidosis. However, no patients manifested major metabolic decompensation. Developmental outcomes correlated more closely with initial metabolic abnormalities than with long-term metabolic control. Increased intake of medical foods resulted in better control but also perturbations in the ratios of essential amino acids and lower z-scores for head circumference. We found no relationship between diet and cognitive outcomes. CONCLUSIONS: Although dietary therapy for cblC patients improves metabolic control, few patients experience metabolic decompensation regardless of diet. Increased incomplete protein intake is not correlated with improvements in outcomes. Overall, outcomes are poor despite early initiation of therapy and regardless of the dietary strategy used.Genet Med advance online publication 02 February 2017.
PURPOSE: Despite implementation of newborn screening (NBS), outcomes in cobalamin C disease (cblC) remain poor. Therapy with hydroxycobalamin and betaine is widely used, but dietary recommendations vary among metabolic centers. We present a longitudinal analysis of the relationship between metabolic control, diet, and outcomes in a cohort of cblC patients. METHODS: We completed a retrospective analysis of 12 patients with cblC referred for abnormal NBS results and followed in our center between 1999 and 2015. RESULTS: Of the patients, 87.5% had intellectual disability and 75% had retinopathy; 16.7% had one episode of mild acidosis. However, no patients manifested major metabolic decompensation. Developmental outcomes correlated more closely with initial metabolic abnormalities than with long-term metabolic control. Increased intake of medical foods resulted in better control but also perturbations in the ratios of essential amino acids and lower z-scores for head circumference. We found no relationship between diet and cognitive outcomes. CONCLUSIONS: Although dietary therapy for cblC patients improves metabolic control, few patients experience metabolic decompensation regardless of diet. Increased incomplete protein intake is not correlated with improvements in outcomes. Overall, outcomes are poor despite early initiation of therapy and regardless of the dietary strategy used.Genet Med advance online publication 02 February 2017.
Authors: Kevin A Strauss; Joan Brumbaugh; Alana Duffy; Bridget Wardley; Donna Robinson; Christine Hendrickson; Silvia Tortorelli; Ann B Moser; Erik G Puffenberger; Nicholas L Rider; D Holmes Morton Journal: Mol Genet Metab Date: 2011-07-12 Impact factor: 4.797
Authors: Jordan P Lerner-Ellis; Jamie C Tirone; Peter D Pawelek; Carole Doré; Janet L Atkinson; David Watkins; Chantal F Morel; T Mary Fujiwara; Emily Moras; Angela R Hosack; Gail V Dunbar; Hana Antonicka; Vince Forgetta; C Melissa Dobson; Daniel Leclerc; Roy A Gravel; Eric A Shoubridge; James W Coulton; Pierre Lepage; Johanna M Rommens; Kenneth Morgan; David S Rosenblatt Journal: Nat Genet Date: 2005-11-27 Impact factor: 38.330
Authors: Martina Huemer; Burkhard Simma; Brian Fowler; Terttu Suormala; Olaf A Bodamer; Jörn Oliver Sass Journal: J Pediatr Date: 2005-10 Impact factor: 4.406
Authors: Cary O Harding; De-Ann M Pillers; Robert D Steiner; Teodoro Bottiglieri; David S Rosenblatt; Jason Debley; K Michael Gibson Journal: J Perinatol Date: 2003 Jul-Aug Impact factor: 2.521
Authors: C Thauvin-Robinet; E Roze; G Couvreur; M-H Horellou; F Sedel; D Grabli; G Bruneteau; C Tonneti; A Masurel-Paulet; D Perennou; T Moreau; M Giroud; H Ogier de Baulny; S Giraudier; L Faivre Journal: J Neurol Neurosurg Psychiatry Date: 2008-02-01 Impact factor: 10.154
Authors: Mohammed Almannai; Ronit Marom; Kristian Divin; Fernando Scaglia; V Reid Sutton; William J Craigen; Brendan Lee; Lindsay C Burrage; Brett H Graham Journal: Mol Genet Metab Date: 2017-06-29 Impact factor: 4.797
Authors: Anna J Esser; Srijan Mukherjee; Ilia A Dereven'kov; Sergei V Makarov; Donald W Jacobsen; Ute Spiekerkoetter; Luciana Hannibal Journal: iScience Date: 2022-08-18